Literature DB >> 15955676

Prevalence of dementia in the elderly in Europe.

C Berr1, J Wancata, K Ritchie.   

Abstract

Dementia is an important public health problem as it is one of the most common diseases in the elderly and a major cause of disability and mortality. This review on dementia is restricted to European Union countries where the overwhelming majority of studies have been undertaken, and will also refer to the EURODEM publications which may be considered to be the principal European reference point in this area. In subjects aged over 65, crude prevalence rates for dementia varied between 5.9% and 9.4%. We discuss the major problems limiting the use of these estimations, limits which may differ according to the area of application, be it etiological research or care provision.

Entities:  

Mesh:

Year:  2005        PMID: 15955676     DOI: 10.1016/j.euroneuro.2005.04.003

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  57 in total

Review 1.  Epidemiology and risk factors of dementia.

Authors:  W M van der Flier; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

2.  Accounting for the relationship between low education and dementia: a twin study.

Authors:  Margaret Gatz; James A Mortimer; Laura Fratiglioni; Boo Johansson; Stig Berg; Ross Andel; Michael Crowe; Amy Fiske; Chandra A Reynolds; Nancy L Pedersen
Journal:  Physiol Behav       Date:  2007-05-21

3.  [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)].

Authors:  T Luck; S G Riedel-Heller; B Wiese; J Stein; S Weyerer; J Werle; H Kaduszkiewicz; M Wagner; E Mösch; T Zimmermann; W Maier; H Bickel; H van den Bussche; F Jessen; A Fuchs; M Pentzek
Journal:  Z Gerontol Geriatr       Date:  2009-07-30       Impact factor: 1.281

4.  Mild Alzheimer's disease: a "position paper".

Authors:  J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

5.  Use of health and social care services in a cohort of Italian dementia patients.

Authors:  Silvia Scalmana; Anteo Di Napoli; Francesco Franco; Nicola Vanacore; Domenico Di Lallo; Maria Letizia Giarrizzo; Gabriella Guasticchi
Journal:  Funct Neurol       Date:  2013 Oct-Dec

6.  Is lipoprotein (a) protective of dementia?

Authors:  Setor K Kunutsor; Hassan Khan; Kristiina Nyyssönen; Jari A Laukkanen
Journal:  Eur J Epidemiol       Date:  2016-07-13       Impact factor: 8.082

7.  Has 'lifetime prevalence' reached the end of its life? An examination of the concept.

Authors:  David L Streiner; Scott B Patten; James C Anthony; John Cairney
Journal:  Int J Methods Psychiatr Res       Date:  2009-12       Impact factor: 4.035

8.  Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail.

Authors:  Fred Andersen; Torgeir A Engstad; Bjørn Straume; Matti Viitanen; Dag S Halvorsen; Samuel Hykkerud; Kjell Sjøbrend
Journal:  BMC Med Res Methodol       Date:  2010-04-29       Impact factor: 4.615

9.  Delphi research exploring essential components and preconditions for case management in people with dementia.

Authors:  Paul-Jeroen Verkade; Berno van Meijel; Cindy Brink; Harmieke van Os-Medendorp; Bauke Koekkoek; Anneke L Francke
Journal:  BMC Geriatr       Date:  2010-08-09       Impact factor: 3.921

10.  Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil.

Authors:  Cecilia M Persson; Asa K Wallin; Sten Levander; Lennart Minthon
Journal:  BMC Neurol       Date:  2009-02-10       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.